Organization

Joanne Kurtzberg

7 clinical trials

Clinical trial

A Phase II Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder

Status: Completed, Estimated PCD: 2023-05-02

Clinical trial

A PHASE I STUDY OF hCT-MSC, AN UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELL PRODUCT, IN ADULTS WITH AUTISM SPECTRUM DISORDER

Status: Active (not recruiting), Estimated PCD: 2024-06-01

Clinical trial

Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries

Status:

Clinical trial

A Compassionate Release Protocol: Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Allogeneic Transplantation Using a Related Haplo-Identical Donor and Unrelated, Umbilical Cord Blood Donor(s) for the Treatment of High Risk Malignancies or Non-Malignant Disorders Requiring Allogeneic Transplantation

Status:

Clinical trial

Phase IA Trial of Intrathecal Administration of Human Umbilical Cord Blood-Derived Cell Therapy (DUOC-01) in Adults With Primary Progressive Multiple Sclerosis (PPMS)

Status: Recruiting, Estimated PCD: 2025-08-30

Clinical trial

A Phase I Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Newborn Infants With Moderate or Severe Hypoxic- Ischemic Neonatal Encephalopathy.

Status: Completed, Estimated PCD: 2019-07-28

Clinical trial

Augmentation of Umbilical Cord Blood Transplantation for Inherited Metabolic Diseases With Intrathecal Administration of Human Umbilical Cord Blood-Derived Oligodendrocyte-Like Cells

Status: Recruiting, Estimated PCD: 2024-10-01